A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact.
Chiara Macchi, Nicola Ferri, Cesare R Sirtori, Alberto Corsini, Maciej Banach, Massimiliano Ruscica. Am J Pathol 2021
24
100

LocusZoom: regional visualization of genome-wide association scan results.
Randall J Pruim, Ryan P Welch, Serena Sanna, Tanya M Teslovich, Peter S Chines, Terry P Gliedt, Michael Boehnke, Gonçalo R Abecasis, Cristen J Willer. Bioinformatics 2010
100


Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data.
Arman Qamar, Robert P Giugliano, Anthony C Keech, Julia F Kuder, Sabina A Murphy, Christopher E Kurtz, Scott M Wasserman, Peter S Sever, Terje R Pedersen, Marc S Sabatine. JAMA Cardiol 2019
22
100

An Update on the Role of PCSK9 in Atherosclerosis.
Ece Yurtseven, Dilek Ural, Kemal Baysal, Lale Tokgözoğlu. J Atheroscler Thromb 2020
8
100

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.
Chiara Caselli, Serena Del Turco, Rosetta Ragusa, Valentina Lorenzoni, Michiel De Graaf, Giuseppina Basta, Arthur Scholte, Raffaele De Caterina, Danilo Neglia. Cardiovasc Diabetol 2019
22
100

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
Karin Leander, Anders Mälarstig, Ferdinand M Van't Hooft, Craig Hyde, Mai-Lis Hellénius, Jason S Troutt, Robert J Konrad, John Öhrvik, Anders Hamsten, Ulf de Faire. Circulation 2016
119
100


PCSK9 induces a pro-inflammatory response in macrophages.
Chiara Ricci, Massimiliano Ruscica, Marina Camera, Laura Rossetti, Chiara Macchi, Alessandra Colciago, Ilaria Zanotti, Maria Giovanna Lupo, Maria Pia Adorni, Arrigo F G Cicero,[...]. Sci Rep 2018
98
100

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
Paul N Hopkins, Joep Defesche, Sigrid W Fouchier, Eric Bruckert, Gérald Luc, Bertrand Cariou, Barbara Sjouke, Trond P Leren, Mariko Harada-Shiba, Hiroshi Mabuchi,[...]. Circ Cardiovasc Genet 2015
71
100

PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering.
Bertrand Cariou, Zufeng Ding, Jawahar L Mehta. Atherosclerosis 2016
13
100

Context-dependence of race self-classification: Results from a highly mixed and unequal middle-income country.
Dóra Chor, Alexandre Pereira, Antonio G Pacheco, Ricardo V Santos, Maria J M Fonseca, Maria I Schmidt, Bruce B Duncan, Sandhi M Barreto, Estela M L Aquino, José G Mill,[...]. PLoS One 2019
10
100

Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Jacqueline M Anderson, Alvaro Cerda, Mario H Hirata, Alice C Rodrigues, Egidio L Dorea, Marcia M S Bernik, Marcelo C Bertolami, Andre A Faludi, Rosario D C Hirata. J Clin Lipidol 2014
21
100

Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition.
Arturo Cesaro, Vanessa Bianconi, Felice Gragnano, Elisabetta Moscarella, Fabio Fimiani, Emanuele Monda, Olga Scudiero, Giuseppe Limongelli, Matteo Pirro, Paolo Calabrò. Biofactors 2020
30
100

PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
Zhiyong Qi, Liang Hu, Jianjun Zhang, Wenlong Yang, Xin Liu, Daile Jia, Zhifeng Yao, Lin Chang, Guanxing Pan, Haoxuan Zhong,[...]. Circulation 2021
33
100

[Design and implementation of the ELSA-Brasil biobank: a prospective study in a Brazilian population].
Alexandre C Pereira, Isabela M Bensenor, Ligia M Fedeli, Cristina Castilhos, Pedro G Vidigal, Viviane Maniero, Claudia M Leite, Robercia A Pimentel, Bruce B Duncan, Jose Geraldo Mill,[...]. Rev Saude Publica 2013
12
100

Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition.
Ben M Brumpton, Lars G Fritsche, Jie Zheng, Jonas Bille Nielsen, Maria Mannila, Ida Surakka, Humaira Rasheed, Gunnhild Åberge Vie, Sarah E Graham, Maiken Elvestad Gabrielsen,[...]. Circ Genom Precis Med 2019
1
100


Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design.
Estela M L Aquino, Sandhi Maria Barreto, Isabela M Bensenor, Marilia S Carvalho, Dóra Chor, Bruce B Duncan, Paulo A Lotufo, José Geraldo Mill, Maria Del Carmen Molina, Eduardo L A Mota,[...]. Am J Epidemiol 2012
394
100

Haploview: Visualization and analysis of SNP genotype data.
Jeffrey C Barrett. Cold Spring Harb Protoc 2009
243
100

Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.
Jin Li, Leslie A Lange, Jeremy Sabourin, Qing Duan, William Valdar, Monte S Willis, Yun Li, James G Wilson, Ethan M Lange. J Hum Genet 2015
28
100

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.
Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, Pravien Abeywickrema, Vijayalakshmi Agnani, Xi Ai, Jen Baysarowich, Noel Byrne, John P Caldwell, Wonsuk Chang,[...]. Cell Chem Biol 2020
18
100

PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.
Shia T Kent, Robert S Rosenson, Christy L Avery, Yii-Der I Chen, Adolfo Correa, Steven R Cummings, L Adrienne Cupples, Mary Cushman, Daniel S Evans, Vilmundur Gudnason,[...]. Circ Cardiovasc Genet 2017
34
100

PCSK9 inhibition and inflammation: A narrative review.
Massimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, Cesare R Sirtori. Atherosclerosis 2019
44
100

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.
Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike,[...]. Circulation 2017
138
100

Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.
Janne Pott, Valentin Schlegel, Andrej Teren, Katrin Horn, Holger Kirsten, Christina Bluecher, Juergen Kratzsch, Markus Loeffler, Joachim Thiery, Ralph Burkhardt,[...]. Circ Genom Precis Med 2018
21
100

Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding.
Shi-Jun Deng, Adekunle Alabi, Hong-Mei Gu, Ayinuer Adijiang, Shucun Qin, Da-Wei Zhang. J Lipid Res 2019
8
100

Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes.
Stéphane Ramin-Mangata, Matthieu Wargny, Matthieu Pichelin, Cédric Le May, Aurélie Thédrez, Valentin Blanchard, Brice Nativel, Raul D Santos, Isabela M Benseñor, Paulo A Lotufo,[...]. Atherosclerosis 2020
9
100

Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis.
Martine Paquette, Dany Gauthier, Ann Chamberland, Annik Prat, Emanuella De Lucia Rolfe, Jon J Rasmussen, Lydia Kaduka, Nabil G Seidah, Sophie Bernard, Dirk L Christensen,[...]. Clin Biochem 2020
12
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.